253 related articles for article (PubMed ID: 24127282)
41. Genetics of Familial Non-Medullary Thyroid Carcinoma (FNMTC).
Diquigiovanni C; Bonora E
Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33946592
[TBL] [Abstract][Full Text] [Related]
42. Loss of heterozygosity at 19p13.2 and 2q21 in tumours from familial clusters of non-medullary thyroid carcinoma.
Prazeres HJ; Rodrigues F; Soares P; Naidenov P; Figueiredo P; Campos B; Lacerda M; Martins TC
Fam Cancer; 2008; 7(2):141-9. PubMed ID: 17823852
[TBL] [Abstract][Full Text] [Related]
43. Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population.
Uchino S; Noguchi S; Kawamoto H; Yamashita H; Watanabe S; Yamashita H; Shuto S
World J Surg; 2002 Aug; 26(8):897-902. PubMed ID: 11965446
[TBL] [Abstract][Full Text] [Related]
44. Genotype Analyses in the Japanese and Belarusian Populations Reveal Independent Effects of rs965513 and rs1867277 but Do Not Support the Role of FOXE1 Polyalanine Tract Length in Conferring Risk for Papillary Thyroid Carcinoma.
Nikitski AV; Rogounovitch TI; Bychkov A; Takahashi M; Yoshiura KI; Mitsutake N; Kawaguchi T; Matsuse M; Drozd VM; Demidchik Y; Nishihara E; Hirokawa M; Miyauchi A; Rubanovich AV; Matsuda F; Yamashita S; Saenko VA
Thyroid; 2017 Feb; 27(2):224-235. PubMed ID: 27824288
[TBL] [Abstract][Full Text] [Related]
45. [A Familial Non Medullary Thyroid Carcinoma (FNMTC) : a clinical and genetic update].
Valdes-Socin H; Palmeira L; Burlacu MC; Daly AF; Bours V; Beckers A
Rev Med Liege; 2016 Dec; 71(12):557-561. PubMed ID: 28387096
[TBL] [Abstract][Full Text] [Related]
46. Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21.
McKay JD; Lesueur F; Jonard L; Pastore A; Williamson J; Hoffman L; Burgess J; Duffield A; Papotti M; Stark M; Sobol H; Maes B; Murat A; Kääriäinen H; Bertholon-Grégoire M; Zini M; Rossing MA; Toubert ME; Bonichon F; Cavarec M; Bernard AM; Boneu A; Leprat F; Haas O; Lasset C; Schlumberger M; Canzian F; Goldgar DE; Romeo G
Am J Hum Genet; 2001 Aug; 69(2):440-6. PubMed ID: 11438887
[TBL] [Abstract][Full Text] [Related]
47. Familial non-medullary thyroid carcinoma (FNMTC): analysis of fPTC/PRN, NMTC1, MNG1 and TCO susceptibility loci and identification of somatic BRAF and RAS mutations.
Cavaco BM; Batista PF; Martins C; Banito A; do Rosário F; Limbert E; Sobrinho LG; Leite V
Endocr Relat Cancer; 2008 Mar; 15(1):207-15. PubMed ID: 18310288
[TBL] [Abstract][Full Text] [Related]
48. Multiple functional variants in long-range enhancer elements contribute to the risk of SNP rs965513 in thyroid cancer.
He H; Li W; Liyanarachchi S; Srinivas M; Wang Y; Akagi K; Wang Y; Wu D; Wang Q; Jin V; Symer DE; Shen R; Phay J; Nagy R; de la Chapelle A
Proc Natl Acad Sci U S A; 2015 May; 112(19):6128-33. PubMed ID: 25918370
[TBL] [Abstract][Full Text] [Related]
49. Risk of Second Malignant Neoplasm in Familial Non-Medullary Thyroid Cancer Patients.
Capezzone M; Sagnella A; Cantara S; Fralassi N; Maino F; Forleo R; Brilli L; Pilli T; Cartocci A; Castagna MG
Front Endocrinol (Lausanne); 2022; 13():845954. PubMed ID: 35311228
[TBL] [Abstract][Full Text] [Related]
50. Association of FOXE1 polyalanine repeat region with papillary thyroid cancer.
Bullock M; Duncan EL; O'Neill C; Tacon L; Sywak M; Sidhu S; Delbridge L; Learoyd D; Robinson BG; Ludgate M; Clifton-Bligh RJ
J Clin Endocrinol Metab; 2012 Sep; 97(9):E1814-9. PubMed ID: 22736773
[TBL] [Abstract][Full Text] [Related]
51. The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors.
Landa I; Ruiz-Llorente S; Montero-Conde C; Inglada-Pérez L; Schiavi F; Leskelä S; Pita G; Milne R; Maravall J; Ramos I; Andía V; Rodríguez-Poyo P; Jara-Albarrán A; Meoro A; del Peso C; Arribas L; Iglesias P; Caballero J; Serrano J; Picó A; Pomares F; Giménez G; López-Mondéjar P; Castello R; Merante-Boschin I; Pelizzo MR; Mauricio D; Opocher G; Rodríguez-Antona C; González-Neira A; Matías-Guiu X; Santisteban P; Robledo M
PLoS Genet; 2009 Sep; 5(9):e1000637. PubMed ID: 19730683
[TBL] [Abstract][Full Text] [Related]
52. Current Knowledge of Germline Genetic Risk Factors for the Development of Non-Medullary Thyroid Cancer.
Hińcza K; Kowalik A; Kowalska A
Genes (Basel); 2019 Jun; 10(7):. PubMed ID: 31247975
[TBL] [Abstract][Full Text] [Related]
53. Mapping of a gene predisposing to familial thyroid tumors with cell oxyphilia to chromosome 19 and exclusion of JUN B as a candidate gene.
Kraimps JL; Canzian F; Jost C; Menet E; Amati P; Levillian P; Harach R; Lesueur F; Barbier J; Romeo G; Bonneau D
Surgery; 1999 Dec; 126(6):1188-94. PubMed ID: 10598206
[TBL] [Abstract][Full Text] [Related]
54. Familial Aggregation and Heritability of Nonmedullary Thyroid Cancer in an Asian Population: A Nationwide Cohort Study.
Lin HT; Liu FC; Lin SF; Kuo CF; Chen YY; Yu HP
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32333767
[TBL] [Abstract][Full Text] [Related]
55. Targeted DNA Sequencing Detects Mutations Related to Susceptibility among Familial Non-medullary Thyroid Cancer.
Yu Y; Dong L; Li D; Chuai S; Wu Z; Zheng X; Cheng Y; Han L; Yu J; Gao M
Sci Rep; 2015 Nov; 5():16129. PubMed ID: 26530882
[TBL] [Abstract][Full Text] [Related]
56. Familial nonmedullary thyroid carcinoma.
Malchoff CD; Malchoff DM
Semin Surg Oncol; 1999; 16(1):16-8. PubMed ID: 9890735
[TBL] [Abstract][Full Text] [Related]
57. Identification of susceptibility gene mutations associated with the pathogenesis of familial nonmedullary thyroid cancer.
Zhu J; Wu K; Lin Z; Bai S; Wu J; Li P; Xue H; Du J; Shen B; Wang H; Liu Y
Mol Genet Genomic Med; 2019 Dec; 7(12):e1015. PubMed ID: 31642198
[TBL] [Abstract][Full Text] [Related]
58. Ultra-rare mutation in long-range enhancer predisposes to thyroid carcinoma with high penetrance.
He H; Li W; Wu D; Nagy R; Liyanarachchi S; Akagi K; Jendrzejewski J; Jiao H; Hoag K; Wen B; Srinivas M; Waidyaratne G; Wang R; Wojcicka A; Lattimer IR; Stachlewska E; Czetwertynska M; Dlugosinska J; Gierlikowski W; Ploski R; Krawczyk M; Jazdzewski K; Kere J; Symer DE; Jin V; Wang Q; de la Chapelle A
PLoS One; 2013; 8(5):e61920. PubMed ID: 23690926
[TBL] [Abstract][Full Text] [Related]
59. Clinical characteristics and outcome of familial nonmedullary thyroid cancer: a retrospective controlled study.
Robenshtok E; Tzvetov G; Grozinsky-Glasberg S; Shraga-Slutzky I; Weinstein R; Lazar L; Serov S; Singer J; Hirsch D; Shimon I; Benbassat C
Thyroid; 2011 Jan; 21(1):43-8. PubMed ID: 20954815
[TBL] [Abstract][Full Text] [Related]
60. Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity.
Capezzone M; Marchisotta S; Cantara S; Busonero G; Brilli L; Pazaitou-Panayiotou K; Carli AF; Caruso G; Toti P; Capitani S; Pammolli A; Pacini F
Endocr Relat Cancer; 2008 Dec; 15(4):1075-81. PubMed ID: 18832444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
